Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Cotadutide in Diabetes Mellitus, Type 2: NCT05294458 Clinical Landscape Report 2026
16 October 2026
NCT05294458 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CNM-Au8 in Amyotrophic Lateral Sclerosis: NCT05299658 Clinical Landscape Report 2026
16 October 2026
NCT05299658 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CNS10-NPC-GDNF(Cedars-Sinai Medical Center) in Amyotrophic Lateral Sclerosis: NCT05306457 Clinical Landscape Report 2026
16 October 2026
NCT05306457 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
LASN-01 in Idiopathic Pulmonary Fibrosis: NCT05331300 Clinical Landscape Report 2026
16 October 2026
NCT05331300 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Denecimig in Hemophilia A: NCT05306418 Clinical Landscape Report 2026
16 October 2026
NCT05306418 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Nerandomilast in Idiopathic Pulmonary Fibrosis: NCT05321069 Clinical Landscape Report 2026
16 October 2026
NCT05321069 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Deupirfenidone in Idiopathic Pulmonary Fibrosis: NCT05321420 Clinical Landscape Report 2026
16 October 2026
NCT05321420 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tofogliflozin Hydrate in Fibrosis, Liver: NCT05327127 Clinical Landscape Report 2026
16 October 2026
NCT05327127 clinical landscape for Fibrosis, Liver: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Rituximab in Myasthenia Gravis: NCT05332587 Clinical Landscape Report 2026
16 October 2026
NCT05332587 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Batoclimab in Myasthenia Gravis: NCT05332210 Clinical Landscape Report 2026
16 October 2026
NCT05332210 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Exagamglogene Autotemcel in Anemia, Sickle Cell: NCT05329649 Clinical Landscape Report 2026
16 October 2026
NCT05329649 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Crizanlizumab-TMCA in Spinocerebellar Ataxias: NCT05334576 Clinical Landscape Report 2026
16 October 2026
NCT05334576 clinical landscape for Spinocerebellar Ataxias: endpoints, sponsor, phase, geography, readouts, asset context and development white space.